Breast Cancer Symposium 2024

We are honoured to have you join us for this paramount event, organised and sponsored by EuroNoxx Medical Group Ltd., in collaboration with the London International Medical School (LIMS) and our esteemed partner, Koning Corporation from the United States of America (USA). This innovative and ambitious programme convenes leading experts from right here in the United Kingdom (UK) and sponsored speakers from the USA to provide comprehensive insights into breast cancer prevention, early detection, and management.

We are resolute in our commitment to ensuring the highest standards of quality and integrity in medical devices and healthcare supplies. We trust that this symposium will not only educate and inspire but also foster new collaborations and innovations in the battle against breast cancer. We appreciate your participation in this critical event.

The journey of our willpower, our faith, and our body has challenges every day. But make no mistakes, our infinite wisdom and courage should be strong enough to resolve to fight - which will never break. So, community programs can nurture your sunny side up, keep you beautiful, and shine a light in the darkness.

"Breast Cancer 2024 Symposium" - can significantly move the needle forward as the world's largest conference solely devoted to cognitive and emotional interaction and exchange among basic scientists and clinicians in breast cancer research who can yield positive social outcomes. This scientific and education symposium, initiated and owned by Euronoxx Medical Group - "Breast Cancer 2024 Symposium" is a strong ethical foundational programme to be such a wonderful science management initiative, building intellectual elements of societal challenges, and compassionate alliance.

This flagship programme redeems a broad age-based and sex-based journey to fight against breast cancer and builds awareness by reducing the stigma of breast cancer through education about screening, symptoms, and therapeutic outcomes. The Breast Cancer 2024 Symposium will take place as an onsite event at Oxford Circus (Bakerloo, Central and Victoria lines) and Bond Street (Central, Jubilee and Elizabeth lines) in collaboration with the London International Medical School (LIMS) and our esteemed partner, Koning Corporation from the USA. This scientific symposium going to be a key event for the cancer research community in breast cancer clinical studies to address multidisciplinary collaboration and education.

Symposium Agenda:-
9:00-9:25: Registration of registered attendees.
9:25-9:30: Welcome Note by Professor Sam Lingam.
9:30-10:00: Dr. Penny Kechagioglou  
10:00-10:30: Dr. Anil Jain  
10:30-11:00: Prof. Justin Stebbing | Same
11:00-11:30: Dr. Timothy Crook | 
 11:45-12:30: Dr. Xiaohua (Roger) Zhang  
 1:15-2:00: Dr. David Bodne.
2:00-2:30: David Georges. 
2:30-3:15: Dr. Jajini Varghese.  
3:45-4:30: Professor Kefah Mokbel.  
4:30-5:00: Closing Remarks by Prof. Justin Stebbing & Prof. Sam Lingam.

 

Others Details

This going to have a strong emphasis on experimental biology, aetiology, prevention, early diagnosis, and screening therapy. Hence, the 2024 symposium is designed to attract a global audience of academic and private physicians and researchers. This scientific program includes panel discussions by experts in clinical, translational research, and recent science discoveries, followed by outstanding lecturers, as well as mind-numbing slide and scientific poster templates, forums, and case studies.

SI NO	Filename	Download
1	BC24_Symposium_EuronoxxMedical.pdf	Download
2	Symposium2024	Download